Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,945 total articles
Aardvark Therapeutics announced voluntary pauses in enrollment and dosing for its Phase 3 ARD-101 trial in Prader-Willi Syndrome and its ARD-201 obesity program following unexpected reversible cardiac observations in a healthy volunteer trial. The company is working with the FDA to determine next steps and plans to provide further guidance in Q2 20…
Viasat, Inc. has announced the appointment of Shekar Ayyar and Jinhy Yoon to its Board of Directors and Strategic Review Committee, aimed at strengthening the board with expertise in technology, finance, and governance. Concurrently, Viasat has entered a cooperation agreement with Carronade Capital Management, a significant shareholder advocating f…
Aduro Clean Technologies Inc. has appointed Scott Smith, an industry veteran with extensive experience in petroleum upgrading, as Program Director for Petroleum Technology Solutions. This strategic hire supports Aduro's advancement of its Hydrochemolytic™ Technology (HCT) in upgrading paraffinic crude oils and bitumen, progressing from lab validati…
Enphase Energy announced it has signed a new safe harbor agreement with a U.S. third-party ownership solar and battery financing company. This agreement, valued at approximately $52 million, covers IQ9 Microinverters for residential and commercial solar projects and is expected to generate revenue between 2027 and 2030. The deal increases Enphase's…
DarkIris Inc., a Hong Kong-based mobile game developer and operator listed on Nasdaq, announced a 16-for-1 share consolidation effective May 11, 2026, to comply with Nasdaq listing standards and optimize its capital structure. This move aims to enhance institutional investor appeal and support the company's growth strategy, which includes leveragin…
LGI Homes has announced the grand opening of Willow Estates, a new single-family home community in Shelby, NC offering 246 move-in-ready homes with modern upgrades and affordable pricing starting in the upper $200,000s. The development targets families and first-time buyers seeking quality homes with convenient access to Charlotte and nearby amenit…
MBX Biosciences reported Q1 2026 financial results highlighting progress in its endocrine and metabolic disorder pipeline. Key updates include the acceptance of Phase 2 trial data of canvuparatide for oral presentation at ENDO 2026, readiness to initiate Phase 3 trial in Q3 2026, and expansion of its obesity program with new candidate nominations. …
vTv Therapeutics announced management's participation in two upcoming investor conferences in May 2026, highlighting their late-stage clinical development of cadisegliatin, an oral adjunctive therapy for type 1 diabetes currently in Phase 3 trials. The company plans to webcast fireside chats providing updates on their pipeline. Cadisegliatin has re…
Freshworks Inc. announced that Tyler Sloat, COO and CFO, will participate in a fireside chat at the 21st Annual Needham Technology, Media & Consumer Conference, with a replay available on their investor relations website. The company highlighted its AI-powered service software solutions trusted by major clients.
Krystal Biotech, a commercial-stage biotechnology company specializing in genetic medicines, announced its participation in the BofA Securities 2026 Health Care Conference. CEO Krish S. Krishnan will engage in a fireside chat and hold investor meetings, with a webcast available for public viewing. The company focuses on innovative gene therapy trea…
NRx Pharmaceuticals has received FDA clearance to begin a phase 2/3 clinical trial testing NRX-101 combined with Robotic-enabled Transcranial Magnetic Stimulation (TMS) versus placebo in patients with treatment-resistant depression and suicidality. The trial aims to enroll 240+ patients at academic, military, and clinical sites across the US. This …
Vericel Corporation reported a 30% increase in Q1 2026 total revenue to $68.4 million, driven by growth in both its MACI and Burn Care franchises. The company achieved a 72% gross margin and a 195% increase in adjusted EBITDA, despite a net loss reduction to $6.3 million. Vericel raised its full-year 2026 revenue guidance by $10 million to a range …
ZenaTech, a Nasdaq-listed AI drone and Drone as a Service provider, announced its agreement to acquire a well-established Australian land surveying and spatial services company, marking its 22nd DaaS acquisition and entry into the Australian and Asia-Pacific markets. The acquisition enhances ZenaTech's presence in infrastructure, public works, and …
Inspired Entertainment, Inc. reported first quarter 2026 revenue of $57.2 million, with a 29% increase in Adjusted EBITDA to $23.7 million and a 41% margin. Despite a 5% revenue decline due to divestitures and restructuring, core business segments, particularly Interactive, showed strong growth—Interactive revenue grew 38% year-over-year. The compa…
Mobilicom Limited (Nasdaq: MOB) will participate in two significant U.S. events, XPONENTIAL 2026 and Loitering Munitions USA, showcasing its cybersecurity-focused autonomous drone and robotics solutions. CEO Oren Elkayam will present on preventing cascade failures in autonomous fleets, highlighting the company's innovation and role in secured auton…
Advanced Flower Capital Inc. announced solid financial results for Q1 2026, including GAAP net investment income of $4.8 million and net asset value per share increase to $7.90. The company repaid dividends exceeding net investment income and initiated a $5 million share repurchase program to enhance shareholder value. AFC's focus on flexible credi…
MasterCraft Boat Holdings, Inc. reported Q3 fiscal 2026 net sales of $78.2 million, a 3% increase year over year, and adjusted net income of $7.2 million, up from $5.0 million in the prior year. Adjusted EBITDA rose to $10.7 million, reflecting improved operational efficiency despite a GAAP loss due to one-time transaction costs related to its pend…
Vera Therapeutics announced that the FDA has granted priority review to the Biologics License Application for atacicept, targeting accelerated approval for treatment of IgA Nephropathy with a PDUFA date set for July 7, 2026. The company is progressing preparations for a U.S. commercial launch pending approval, strengthened its executive team, and r…
ARKO Corp., a major U.S. convenience store operator and fuel wholesaler, reported improved Q1 2026 financials with net loss narrowing to $5.6 million from $12.7 million a year ago. Adjusted EBITDA surged 65.1% to $50.9 million driven by growth in merchandise margins and same-store fuel margins. The company made substantial progress in converting re…
Repligen Corporation, a leader in bioprocessing technologies for biopharmaceutical manufacturing, announced its participation in the Bank of America Securities 2026 Global Healthcare Conference with CFO Jason Garland leading a discussion. The event will be webcast live and available for replay, highlighting the company's ongoing engagement with inv…
nCino, Inc. announced that Vision Credit Union, a major Alberta-based credit union with significant agricultural loan exposure, has chosen nCino’s commercial lending, banking advisor, and automated spreading solutions to digitize and enhance its lending operations. The new technology will automate manual workflows and provide AI-driven insights, en…
SL Green Realty Corp., Manhattan's largest office landlord, announced that One Madison Avenue was honored with the 2026 Urban Land Institute Award for Excellence in Office Development. The project exemplifies adaptive reuse, sustainability, and high tenant demand, with the building achieving 100% occupancy and notable rents. The redevelopment featu…
BriaCell Therapeutics announced the addition of NYU Langone Health's Perlmutter Cancer Center as a site for its pivotal Phase 3 clinical trial evaluating Bria-IMT™ immunotherapy in advanced metastatic breast cancer. The study tests Bria-IMT combined with an immune checkpoint inhibitor versus physician's choice treatment. The trial has FDA Fast Trac…
Annovis Bio's CEO will present on the multi-protein model of Alzheimer's Disease, advocating a shift from the traditional single-protein focus to targeting multiple neurotoxic proteins. The company's lead drug, buntanetap, targets several misfolded proteins and is currently in Phase 3 trials, showing promising clinical benefits and biomarker data.
MACOM Technology Solutions Holdings, Inc. announced robust fiscal second quarter 2026 results, with revenue of $289 million, a 22.5% increase year-over-year, and strong margin expansion. Adjusted net income rose significantly to $84.3 million, or $1.09 per diluted share. The company projects continued growth for the fiscal third quarter with expect…
